Q4 2020 Entera Bio Ltd Earnings Call Transcript
Good morning, and welcome to Entera Bio's conference call to discuss the financial and operating results from the year ended December 31, 2020. (Operator Instructions)
I would now like to turn the call over to Jon Lieber, the U.S.-based CFO of Entera. Please go ahead.
Thank you, and welcome to the call. Joining me on today's call are Spiros Jamas, our CEO; Art Santora, our CMO; and Phillip Schwartz, our President of R&D.
A press release announcing Entera's financial and operating results for the year ended December 31, 2020, was issued earlier today. For those of you who have not yet seen it, it is available on the Investors section of our website, www.enterabio.com. On our call this morning, we will share with you a business update and review of our financial results, which will be followed by a question-and-answer session.
Before we begin our prepared remarks, I would like to remind you that various statements we make
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
